Keywords: BB Biotech, Vontobel Group, Restructuring, Privatization, Investment fund

BB Biotech rejects privatization proposal by Vontobel Group

Article | 16 July 2012

Print This

Swiss biotechnology investment fund BB Biotech (SIX: BION) has confirmed that Vontobel Group has made a proposal to restructure ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in